Not Yet RecruitingNCT07602335
Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants
Medication studyAges 18–55United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- Overland ParkSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: October 22, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 24
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT07602335
- Official title
Show the full official title
A Phase 1, First-In-Human, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of MCAM in Randomized Healthy Adult Participants (Double-Blind)
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Overland Park
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center at San Antonio, a university.
Does this study involve medication?
Yes. The study involves medication, including MCAM.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
